BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1875114)

  • 1. [A case of chronic myeloid leukemia with cytogenetic remission and disappearance of Ph1 positive cells due to interferon-alpha administration].
    Yoshida M; Fujiwara Y; Yoshinaga H; Maeda T; Mori Y; Nonaka K; Senoo K; Atsui F
    Nihon Naika Gakkai Zasshi; 1991 May; 80(5):766-7. PubMed ID: 1875114
    [No Abstract]   [Full Text] [Related]  

  • 2. [One-year remission of chronic myelogenous leukemia (CML) after discontinuation of interferon-alpha].
    Kobayashi Y; Kimura S; Tanaka K; Kimura S; Wada K; Ozawa M; Maruo N; Kondo M
    Rinsho Ketsueki; 1990 Jul; 31(7):1013-6. PubMed ID: 2214181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disappearance of Philadelphia chromosomes after remission induction in lymphoid crisis of chronic myelogenous leukemia].
    Nagafuji K; Iwakiri R; Miyamoto T; Okamura H; Yokota E; Matsumoto I
    Rinsho Ketsueki; 1992 Sep; 33(9):1226-30. PubMed ID: 1433945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha interferon: perspectives in the biotherapy of chronic myelogenous leukemia.
    Terebelo HR
    Oncol Nurs Forum; 1991; 18(1 Suppl):5-9. PubMed ID: 1997975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon induced cytogenetic improvement in CGL patients in haematological relapse post allograft.
    Aitchison R; Collins P; Newland AC
    Bone Marrow Transplant; 1990 Dec; 6(6):453. PubMed ID: 2097016
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bone marrow transplantation in chronic myeloid leukemia].
    Milone JH; Bordone J; Etchegoyen O; Napal J; Prates MV; Morales VH
    Medicina (B Aires); 1999; 59(1):1-10. PubMed ID: 10349111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetics and molecular analysis in chronic myelogenous leukemia patients treated by interferon and chemotherapy.
    Guilhot F; Ahmad M; Mahon FX; Dreyfus B; Brizard A; Huret JL; Kitzis A; Tanzer J
    Nouv Rev Fr Hematol (1978); 1990; 32(5):287-8. PubMed ID: 2099398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic follow-up after allogeneic bone-marrow transplantation for Ph1-positive chronic myelogenous leukemia.
    Alimena G; De Cuia MR; Mecucci C; Arcese W; Mauro F; Screnci M; Mancini M; Cedrone M; Nanni M; Montefusco E
    Bone Marrow Transplant; 1990 Feb; 5(2):119-27. PubMed ID: 2310876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic myelogenous leukemia maintained in remission by interferon alpha presenting with bladder cancer].
    Kobayashi H; Ogawa T
    Rinsho Ketsueki; 1989 Jul; 30(7):1093-4. PubMed ID: 2810796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose interferon-alpha in Ph+ chronic myeloid leukemia: clinical cytogenetic and cell culture study.
    Russo D; Zuffa E; Motta MR; Santucci MA; Fanin R; Testoni N; Celso B; Visani G; Baccarani M; Tura S
    Haematologica; 1988; 73(6):499-502. PubMed ID: 3148512
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of chronic myelogenous leukaemia with interferons.
    Talpaz M; Kurzrock R; Kantarjian H; Gutterman J
    Cancer Surv; 1989; 8(4):793-8. PubMed ID: 2701727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies of natural interferon alpha (HLBI) in chronic myelogenous leukemia--a multi-institutional cooperative study in Japan].
    Koyama S; Moriyama Y; Shibata A; Miura Y; Abe T; Asano S; Miyazaki T; Miura A; Kariyone S; Toyama K
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2959-66. PubMed ID: 3052301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC
    Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon treatment in chronic myeloid leukemia].
    Simonsson B
    Nord Med; 1992; 107(3):76-7, 79. PubMed ID: 1549456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent progress in therapy for chronic myelogenous leukemia].
    Urabe A
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The assessment of therapeutic success in chronic myeloid leukemia].
    Griesshammer M; Hehlmann R; Heimpel H
    Dtsch Med Wochenschr; 1995 Apr; 120(17):620-5. PubMed ID: 7537652
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of chronic myeloid leukemia in chronic phase with interferons].
    Guilhot F
    Pathol Biol (Paris); 1988 Dec; 36(10):1179-81. PubMed ID: 3070457
    [No Abstract]   [Full Text] [Related]  

  • 19. [Natural interferon-alpha induced cytogenetic complete remission in a patient with chronic myelocytic leukemia, diagnosed in early chronic phase with basophilia and normal blood cell counts].
    Koyama S; Moriyama Y; Aoki A; Furukawa T; Narita M; Wada K; Kishi K; Takahashi M; Koike T; Shibata A
    Rinsho Ketsueki; 1992 Feb; 33(2):227-31. PubMed ID: 1635174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic myeloid leukemia--case report].
    Hentrich M; Stoetzer OJ; Salat C; Ledderose G
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2617. PubMed ID: 12469273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.